Qiagen NV QGEN:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
42.98UNCH (UNCH)
Volume
22,385
Close
42.98quote price arrow up+0.30 (+0.70%)
Volume
1,289,708
52 week range
34.77 - 47.74
Loading...
  • Open43.39
  • Day High43.51
  • Day Low42.92
  • Prev Close42.68
  • 52 Week High47.74
  • 52 Week High Date07/27/23
  • 52 Week Low34.77
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap9.514B
  • Shares Out221.36M
  • 10 Day Average Volume1.48M
  • Dividend-
  • Dividend Yield-
  • Beta0.42
  • YTD % Change-4.01

KEY STATS

  • Open43.39
  • Day High43.51
  • Day Low42.92
  • Prev Close42.68
  • 52 Week High47.74
  • 52 Week High Date07/27/23
  • 52 Week Low34.77
  • 52 Week Low Date10/30/23
  • Market Cap9.514B
  • Shares Out221.36M
  • 10 Day Average Volume1.48M
  • Dividend-
  • Dividend Yield-
  • Beta0.42
  • YTD % Change-4.01

RATIOS/PROFITABILITY

  • EPS (TTM)1.53
  • P/E (TTM)28.17
  • Fwd P/E (NTM)20.52
  • EBITDA (TTM)650.583M
  • ROE (TTM)9.38%
  • Revenue (TTM)1.965B
  • Gross Margin (TTM)62.77%
  • Net Margin (TTM)17.37%
  • Debt To Equity (MRQ)39.65%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date01/30/2024
  • Div Amount1.3196
  • Split Date-
  • Split Factor-

Latest On Qiagen NV

 

Profile

MORE
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other...
Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Address
Hulsterweg 82
Venlo
5912 PL
Netherlands